Prudential plc’s AbbVie ABBV Stock Holding History

Prudential plc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$34.5M	Buy	158,795 +2,574	+2%	+$571K	0.2%	50
2025 Q4	$35.7M	Sell	156,221 -319	-0.2%	-$72.7K	0.28%	45
2025 Q3	$36.2M	Sell	156,540 -16,705	-10%	-$3.4M	0.27%	42
2025 Q2	$32.2M	Sell	173,245 -2,187	-1%	-$406K	0.19%	45
2025 Q1	$36.8M	Buy	175,432 +37,858	+28%	+$7.36M	0.18%	36
2024 Q4	$24.4M	Sell	137,574 -26,926	-16%	-$4.95M	0.12%	63
2024 Q3	$32.5M	Buy	164,500 +3,164	+2%	+$591K	0.16%	43
2024 Q2	$27.7M	Buy	161,336 +15,051	+10%	+$2.49M	0.19%	49
2024 Q1	$26.6M	Sell	146,285 -73,939	-34%	-$12.7M	0.2%	53
2023 Q4	$34.1M	Buy	220,224 +10,933	+5%	+$1.59M	0.35%	40
2023 Q3	$31.2M	Buy	209,291 +25,858	+14%	+$3.8M	0.35%	37
2023 Q2	$24.7M	Sell	183,433 -7,388	-4%	-$1.08M	0.29%	51
2023 Q1	$30.4M	Sell	190,821 -2,953	-2%	-$451K	0.36%	37
2022 Q4	$31.3M	Buy	193,774 +37,446	+24%	+$5.74M	0.39%	33
2022 Q3	$21M	Buy	156,328 +49,498	+46%	+$7.1M	0.33%	36
2022 Q2	$16.4M	Buy	106,830 +26,714	+33%	+$4.08M	0.3%	48
2022 Q1	$13M	Buy	80,116 +8,330	+12%	+$1.21M	0.19%	63
2021 Q4	$9.72M	Sell	71,786 -3,949	-5%	-$466K	0.13%	71
2021 Q3	$8.17M	Sell	75,735 -164,738	-69%	-$18.8M	0.11%	75
2021 Q2	$27.1M	Sell	240,473 -665,297	-73%	-$74.9M	0.25%	64
2021 Q1	$98M	Sell	905,770 -446,578	-33%	-$47.8M	0.68%	32
2020 Q4	$145M	Sell	1,352,348 -543,381	-29%	-$52.2M	0.77%	18
2020 Q3	$166M	Sell	1,895,729 -463,591	-20%	-$43.6M	0.83%	11
2020 Q2	$232M	Buy	2,359,320 +143,770	+6%	+$12.7M	1.12%	9
2020 Q1	$169M	Buy	2,215,550 +561,839	+34%	+$47.9M	0.9%	20
2019 Q4	$146M	Sell	1,653,711 -236,096	-12%	-$19.6M	0.62%	55
2019 Q3	$143M	Sell	1,889,807 -359,255	-16%	-$24.6M	0.42%	68
2019 Q2	$164M	Sell	2,249,062 -68,307	-3%	-$5.37M	0.5%	53
2019 Q1	$187M	Buy	2,317,369 +69,098	+3%	+$5.65M	0.67%	36
2018 Q4	$207M	Sell	2,248,271 -151,373	-6%	-$13.3M	0.83%	27
2018 Q3	$227M	Sell	2,399,644 -285,626	-11%	-$27.1M	0.73%	30
2018 Q2	$249M	Buy	2,685,270 +263,488	+11%	+$25.7M	0.78%	28
2018 Q1	$229M	Sell	2,421,782 -285,633	-11%	-$31.4M	0.72%	32
2017 Q4	$262M	Sell	2,707,415 -1,903,018	-41%	-$179M	0.8%	22
2017 Q3	$410M	Sell	4,610,433 -1,860,682	-29%	-$142M	1.29%	11
2017 Q2	$469M	Sell	6,471,115 -550,777	-8%	-$37M	1.54%	7
2017 Q1	$458M	Buy	7,021,892 +10,866	+0.2%	+$683K	1.53%	8
2016 Q4	$439M	Buy	7,011,026 +786,487	+13%	+$48M	1.54%	8
2016 Q3	$393M	Sell	6,224,539 -740,707	-11%	-$48M	1.48%	10
2016 Q2	$431M	Sell	6,965,246 -1,510,682	-18%	-$92.1M	1.69%	7
2016 Q1	$484M	Sell	8,475,928 -639,594	-7%	-$35.6M	1.96%	4
2015 Q4	$540M	Sell	9,115,522 -65,421	-0.7%	-$3.77M	2.19%	4
2015 Q3	$500M	Sell	9,180,943 -467,231	-5%	-$30.4M	2.13%	6
2015 Q2	$648M	Buy	9,648,174 +2,046,632	+27%	+$134M	2.47%	5
2015 Q1	$445M	Buy	7,601,542 +1,298,588	+21%	+$78.5M	1.96%	6
2014 Q4	$412M	Sell	6,302,954 -642,672	-9%	-$40.5M	1.75%	7
2014 Q3	$401M	Buy	6,945,626 +6,044,763	+671%	+$336M	1.66%	8
2014 Q2	$50.8M	Buy	900,863 +4,500	+0.5%	+$236K	0.21%	131
2014 Q1	$46.1M	Buy	896,363 +201,800	+29%	+$10.2M	0.2%	129
2013 Q4	$36.7M	Buy	694,563 +70,409	+11%	+$3.46M	0.16%	148
2013 Q3	$27.9M	Buy	624,154 +311,300	+100%	+$13.8M	0.14%	153
2013 Q2	$12.9M	Buy	+312,854	New	+$13.7M	0.07%	181

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Prudential plc's ABBV Position: Q1 2026 in Review

Prudential plc increased its AbbVie (ABBV) stake by 1.6% in Q1 2026, buying an estimated $571K and bringing the position to 158,795 shares worth $34.5M. The position accounts for 0.2% of the portfolio, ranked #50.

Prudential plc first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $648M in Q2 2015. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Prudential plc held 158,795 shares of AbbVie worth $34.5M as of Q1 2026.
Prudential plc bought 2,574 AbbVie shares in Q1 2026, an estimated $571K.
AbbVie made up 0.2% of Prudential plc's portfolio in Q1 2026, its #50 holding.
Prudential plc first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Prudential plc's AbbVie position peaked at $648M in Q2 2015.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Prudential plc's 13F filing for Q1 2026, filed 14 May 2026.